In support of this hypothesis, we found that downregulation of Bit1 specifically enhanced the metastatic property of tumor cells with no significant impact on their tumorigenicity, and the metastatic foci of Bit1 knockdown cells showed increased Erk activation. This evidence concerns the gene PTRH2 and neoplasm.